Respiratory viruses spread before symptoms appear, starting infections during casual dinners, public transit rides, or workplace meetings while carriers still feel healthy.
With cold weather driving up respiratory illness rates, understanding infectious timelines provides practical daily guidance. Joaquín Lamela López, a pulmonology specialist at Clínica Joaquín Lamela, outlined a precise transmission calendar for both influenza and COVID-19.
Influenza Transmission Window
Influenza transmission begins before the first physical discomfort materializes. Someone waking up with a fever and muscle aches has already spread the virus to coworkers or family members the day before. The highest risk period spans the initial phase of the illness.
Lamela said that “el pico de mayor contagio” occurs “los tres primeros días” when patients feel worst and viral shedding peaks. The transmission window extends beyond that initial spike. Lamela indicated that “puede contagiarse los siete primeros días, incluso hasta los diez primeros,” meaning recovering patients can remain contagious into their fourth or fifth day.
COVID-19 Contagion Timeline
COVID-19 transmission starts even earlier than influenza. Lamela explained that “la covid puede contagiarse desde dos o tres días antes de empezar los síntomas,” which explains how the virus circulates rapidly among asymptomatic carriers.
Peak transmissibility for COVID-19 aligns with the onset of early warning signs.
Lamela placed “el pico de mayor contagio al inicio de los síntomas y los días siguientes.”
Total transmission duration for COVID-19 lasts slightly longer overall. Lamela said that “puede contagiarse durante 8-10 días, desde el inicio de los síntomas,” creating a total infectious window of roughly two weeks when factoring in pre-symptomatic days.
Public Health Recommendations
Both viruses share parallel transmission patterns, featuring pre-symptomatic spread, early symptom spikes, and week-long contagiousness. Public health authorities recommend frequent handwashing, indoor ventilation, covering coughs, and wearing masks around vulnerable populations when experiencing respiratory symptoms. Vaccines remain available for both illnesses, targeted primarily at high-risk groups to mitigate severe outcomes.
Worth a look